PharmEasy: A difficult prognosis
Parent API Holdings seems to be banking on FOMO to raise public money at 500% more than what it was valued at nine months ago.
22 November, 2021•15 min
0
22 November, 2021•15 min
0
Getting your Trinity Audio player ready...
Why read this story?
Editor's note: API Holdings, parent of online pharmacy platform PharmEasy, is on track to set a record for the fastest listing by a unicorn. In April this year, the company raised $350 million from investors, taking it past the billion dollar mark for the first time. Earlier this month, it filed its draft IPO prospectus to float a public issue in the current fiscal year itself. That, if it happens, will see beauty products company Nykaa—which became a $1 billion company in March last year and went on to list earlier this month—lose the tag for the fastest listing by a unicorn. Besides, API Holdings is not looking to raise any small sum. It wants to issue fresh equity to raise about $900 million. It last raised funds in October, to be valued at $5.6 billion, and is working on a pre-IPO placement that is likely to determine the final size and pricing of its issue. Trading in unlisted shares of the company values it at over $9 billion, a whopping 500% increase in the last nine months. The BSE Healthcare index, …
More in Internet
Internet
RBI’s fraud fix could give banks a headache
The regulator’s proposals to introduce checks and safety features in instant payments, if implemented, may end up testing banks.
You may also like
Business
IPO pipeline likely to stall despite SEBI flexibility
Promoters balk at smaller issues and uncertain pricing, choosing to wait out volatility.
Business
MFs hold up India’s IPO market, their investors foot the bill
As retail interest in public issuances fades, mutual funds are filling the gap—funding promoter exits and delivering subpar returns to the very investors they represent.
Internet
An indebted Captain Fresh seeks an IPO bailout
The seafood company solved its demand problem by aggressively buying global distributors. Now it has a financing problem that it can't solve without public money.